Showing 3051-3060 of 4104 results for "".
- Foamix’s Rosacea Candidate Shows Promise in Phase 3 Studieshttps://practicaldermatology.com/news/foamixs-rosacea-candidate-shows-promise-in-phase-3-studies-1/2460286/Foamix Pharmaceuticals Ltd.’s FMX103 1.5% Topical Minocycline Foam for rosacea performed well in an integrated efficacy analysis of two pivotal Phase 3 clinical trials presented at the 17th Annual South Beach Symposium in Dermatology in Miami,
- Aerolase and Eucerin Join Forces to Optimize Patient Outcomes in Laser Treatmentshttps://practicaldermatology.com/news/aerolase-and-eucerin-join-forces-to-optimize-patient-outcomes-in-laser-treatments-1/2460277/Aerolase and Eucerin are working together to optimize laser treatment protocols in the D-A-CH-region (Germany-Austria-Switzerland). Furthermore, both companies will develop therapies for adjunctive care post-laser treatments. Both companies will also conduct a joint symposium
- Allergan Launches New Philanthropic Program Benefitting Kids with Upper Limb Spasticityhttps://practicaldermatology.com/news/allergan-launches-new-philanthropic-program-benefitting-kids-with-upper-limb-spasticity/2460274/Allergan is launching the Be The Difference philanthropic program to support children and their families who may benefit from treatment with Botox (onabotulinumtoxinA) for pediatric upper limb spasticity. Botox is approved to treat increased muscle stiffness in children 2 to 17 years of
- Ortho Dermatologics Opens 2020 Aspire Higher Scholarship Programhttps://practicaldermatology.com/news/ortho-dermatologics-opens-2020-aspire-higher-scholarship-program/2460273/Bausch Health Companies Inc. and its dermatology business, Ortho Dermatologics opened of the application process for its 2020 Aspire Higher scholarship program. The program, which began in 2012, will award nine students who have been treated for a dermatologic condition with a
- Derms Still Need Disaster Preparedness Traininghttps://practicaldermatology.com/news/derms-still-need-disaster-preparedness-training/2460271/The dermatology community is inadequately prepared for a biological disaster and would benefit from a formal preparedness training program, according to a study from the George Washington University (GW) that appears in the Jour
- Dermal Fillers Restore Youthful Facial Movement Toohttps://practicaldermatology.com/news/dermal-fillers-restore-youthful-facial-movement-too-1/2460269/Dermal fillers do more than just fill in wrinkles, they also restore a more youthful pattern of facial movement and expressiveness, according to a
- BioPharmX Corporation and Timber Pharmaceuticals LLC Announce Mergerhttps://practicaldermatology.com/news/biopharmx-corporation-and-timber-pharmaceuticals-llc-announce-merger/2460267/BioPharmX Corporation and Timber Pharmaceuticals LLC have entered into a definitive merger agreement. Under the terms of the merger agreement, subject to the approval of BioPharmX's stockholders and Timber's members, a wholly-owned subsidiary of BioPharmX will be merged wit
- Final Data Support Efficacy of Revian Red System for Hair Growthhttps://practicaldermatology.com/news/final-data-support-efficacy-of-revian-red-system-for-hair-growth/2460260/Final data from a randomized, double-blind study of the Revian Red hair growth system demonstrated the ability of the system to successfully stop hair loss and subsequently grow new hair. Findings were presented at the 2020 Winter Clinical Dermatology Conference – Hawaii and are <
- South Beach Symposium Poised for 18th Miami Conferencehttps://practicaldermatology.com/news/south-beach-symposium-poised-for-18th-miami-conference/2460253/The 18th Annual South Beach Symposium takes place in Miami Beach next month. Organizers say the annual conference boasts an extensive agenda, with in-depth pre-conference offerings, and sessions topics covering the latest and most well-supported knowledge in clinical and aesthetic dermatology. Ro
- Patients Report 95 Percent Satisfaction Rate with Mohs Surgery for Melanomahttps://practicaldermatology.com/news/patients-report-95-percent-satisfaction-rate-with-mohs-surgery-for-melanoma-2/2460252/Patients who received Mohs surgery to treat melanoma reported a 95 percent long-term satisfaction rate with their results, according to a new study by UT Southwestern Medical Center dermatologists. The study, published in Dermatologic Surgery, is the first to poll pat